About IMC
Immuron Limited (IMC) is an Australian biopharmaceutical company engaged in the development and commercialization of orally delivered targeted polyclonal antibodies for the treatment of inflammation-related diseases and infectious diseases.
Find out what a historical investment in Immuron would be worth today using our IMC stock calculator.
Market Capitalisation
$14.53M
Price-earnings ratio
-3.49
Dividend yield
-
High today
$0.04
Low today
$0.04
Open price
$0.04
52-week high
$0.10
52-week low
$0.03
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in IMC
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in IMC on Stake
- Buy IMC from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
IMC related stocks